#EMBARK trial: Age-stratified analysis of enzalutamide in high-risk biochemically recurrent #ProstateCancer. Neal Shore @CURCMB and @zklaassen_md @GACancerCenter discuss this post hoc analysis by age and the importance of personalized treatment decisions &gt;
#EMBARK #ProstateCancer